In the present study, we, for the first time, found c-KIT as a new target of Artemisinin, and further confirmed Artemisinin's effect on regulating the KIT/PI3K/AKT pathway to inhibit the EMT signals and suppressing growth, migration, and invasion of melanoma (Fig.12). Here, AKT1 is linked to melanoma.